Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Bio (NQ: CBIO )

5.700 USD +0.010 (+0.18%)
Streaming Delayed Price Updated: 7:16 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Catalyst Bio

< Previous 1 2 3 4 5 Next >
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference
From GlobeNewswire News Releases
Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
From GlobeNewswire News Releases
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
From GlobeNewswire News Releases
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference
From GlobeNewswire News Releases
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
From GlobeNewswire News Releases
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors
From GlobeNewswire News Releases
Catalyst Biosciences to Present at 32nd Annual Piper Sandler Virtual Healthcare Conference
From GlobeNewswire News Releases
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
From GlobeNewswire News Releases
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
From GlobeNewswire News Releases
Catalyst Biosciences Receives US Patent for its Anti-Complement Factor 3 Portfolio of Engineered Proteases
CB 2782-PEG patent protection extended until at least 2038 
From GlobeNewswire News Releases
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
From GlobeNewswire News Releases
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
From GlobeNewswire News Releases
Softlab9 Target Acquisition CleanGo GreenGo Signs Supply Agreement
From ACCESSWIRE
Catalyst Biosciences Reports Second Quarter 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
From GlobeNewswire News Releases
Catalyst Biosciences Added to Russell 2000 Index
From GlobeNewswire News Releases
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Appoints Charles Democko, Senior Vice President, Regulatory Affairs
From GlobeNewswire News Releases
Catalyst Biosciences Presents Preclinical FIX Gene Therapy Data in an Oral Presentation at the World Federation of Hemophilia Virtual Summit 2020
CB 2679d-GT demonstrates robust expression of FIX in multiple preclinical models 
From GlobeNewswire News Releases
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.